AnGes Inc
TSE:4563
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
AnGes Inc
Other Current Assets
AnGes Inc
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
AnGes Inc
TSE:4563
|
Other Current Assets
¥498.9m
|
CAGR 3-Years
3%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-10%
|
|
|
SanBio Co Ltd
TSE:4592
|
Other Current Assets
¥395.6m
|
CAGR 3-Years
16%
|
CAGR 5-Years
6%
|
CAGR 10-Years
-2%
|
|
|
GNI Group Ltd
TSE:2160
|
Other Current Assets
¥928m
|
CAGR 3-Years
-5%
|
CAGR 5-Years
19%
|
CAGR 10-Years
37%
|
|
|
PeptiDream Inc
TSE:4587
|
Other Current Assets
¥1.1B
|
CAGR 3-Years
28%
|
CAGR 5-Years
25%
|
CAGR 10-Years
27%
|
|
|
Takara Bio Inc
TSE:4974
|
Other Current Assets
¥1.9B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
20%
|
CAGR 10-Years
4%
|
|
|
O
|
Oncolys Biopharma Inc
TSE:4588
|
Other Current Assets
¥395.3m
|
CAGR 3-Years
-11%
|
CAGR 5-Years
6%
|
CAGR 10-Years
30%
|
|
AnGes Inc
Glance View
AnGes, Inc. engages in the research and development of gene-based medical products. The company is headquartered in Ibaraki-Shi, Osaka-Fu and currently employs 131 full-time employees. The company went IPO on 2002-09-25. The firm is involved in the development of hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, among others. As of December 31, 2012, the Company had four consolidated subsidiaries. On January 31, 2013, the Company sold a 95.3% stake of a Osaka-based subsidiary to ISHIHARA SANGYO KAISHA LTD.
See Also
What is AnGes Inc's Other Current Assets?
Other Current Assets
498.9m
JPY
Based on the financial report for Dec 31, 2025, AnGes Inc's Other Current Assets amounts to 498.9m JPY.
What is AnGes Inc's Other Current Assets growth rate?
Other Current Assets CAGR 10Y
-10%
Over the last year, the Other Current Assets growth was 244%. The average annual Other Current Assets growth rates for AnGes Inc have been 3% over the past three years , -15% over the past five years , and -10% over the past ten years .
